Travelit is indicated in- Motion sickness: Travelit is indicated for the prevention and treatment of nausea and vomiting. PONV (Postoperative nausea & vomiting) Meniere's disease etc.
Cyclizine Hydrochloride is an US FDA approved antihistaminic antiemetic drug. It possesses anticholinergic and antiemetic properties. It reduces excitability of inner ear labyrinth and acts directly on vomiting (Emetic) centre in the brain stem.
Motion Sickness: Adults : 1 Tablet (50 mg) Children: (6 years & above) : 1/2 Tablet (25 mg). 1 tablet should be taken at least 30 minutes before journey (before or after meal), repeat 1 tablet if journey is more than 6 hours Postoperative Nausea & Vomiting, Meniere's disease: Adults : 1 Tablet (50 mg) every 6-8 hours daily Children: (6 years & above) : 1/2 Tablet (25 mg) every 6-8 hours daily
Itching or skin rashes, swelling of the face, lips or throat, difficulty in breathing or wheeziness.
Hypersensitivity to the active substance or to the other excipients. Cyclizine is contraindicated in the presence of acute alcohol intoxication. The anti-emetic properties of cyclizine may increase the toxicity of alcohol.
Always consult a registered doctor before taking any medicine. This information is for general knowledge only.
Travelit may have additive effects with alcohol and other CNS depressants e.g. hypnotics, tranquillisers, anaesthetics, antipsychotics & barbiturates. It enhances the soporific effect of pethidine & also counteract the haemodynamic benefits of opioid analgesics.
Travelit should be used with caution and appropriate monitoring in patients with glaucoma, urinary retention, obstructive disease of the gastrointestinal tract, hepatic disease, hypertension, epilepsy, severe heart failure.